Trademark Search in Canada

NOGRADERM

View On IC.GC.CA

REGISTERED

on 24 Nov 2023

Last Applicant/ Owned by

NOGRA PHARMA LIMITED

33 Sir John Rogerson's QuayDublin2

Serial Number

2071565 filed on 28^th Sept 2020

Registration Number

TMA1210548 registered on 24^th Nov 2023

Registration expiry Date

28^th Sept 2030

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

M5H4E3

NOGRADERM

Trademark usage description

pharmaceutical preparations for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and Read More

Vienna Information

19 . 13 . 1

Medical or surgical apparatus, instruments or utensils, prostheses, medicinesAppareils, instruments ou ustensiles de chirurgie ou de médecine, prothèses, médicaments

19 . 13 . 21

Phials, capsules, pills, tablets, suppositoriesAmpoules, capsules, pilules, tablettes, suppositoires

14 . 1 . 13

Chains, links of chainChaînes, anneaux de chaînes

14 . 1 . 15

Links of chainAnneaux de chaînes

24 . 13 . 1

Greek cross, St. Andrew's crossCroix grecque ou de Saint-André

24 . 13 . 9

Crosses formed by intersecting linesCroix formées de lignes qui se coupent

29 . 1 . 4

BlueBleu

29 . 1 . 8

BlackNoir

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; dermatological preparations for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; antibiotic dermatological products, namely, creams and gels for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; dermatological pharmaceutical substances for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; dermatological pharmaceutical products, namely, creams and gels for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; gels for dermatological use for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases; creams for dermatological use for the treatment of immune-inflammatory mediated dermatological diseases and conditions, namely, acne and psoriasis, and skin pigmentation diseases

Classification kind code

Class [042]
Research and development for the pharmaceutical industry; pharmaceutical research and development; pharmaceutical products development; consultancy relating to pharmaceutical research and development.

Classification kind code

Mark Details

Serial Number

2071565

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 11^th Apr 2022	Search Recorded
Submitted for opposition 20 on 11^th Apr 2022	Examiner's First Report
Submitted for opposition 223 on 11^th Apr 2022	Total Provisional Refusal
Submitted for opposition 256 on 18^th Oct 2021	Notification of Possible Opposition Sent
Submitted for opposition 48 on 4^th Mar 2021	Agent Changed
Submitted for opposition 257 on 17^th Dec 2020	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 16^th Dec 2020	Formalized
Submitted for opposition 1 on 16^th Dec 2020	Created
Submitted for opposition 228 on 28^th Sept 2020	International Registration
Submitted for opposition 30 on 28^th Sept 2020	Filed

NOGRADERM

Classification Information

Classification kind code

Class [042]Research and development for the pharmaceutical industry; pharmaceutical research and development; pharmaceutical products development; consultancy relating to pharmaceutical research and development.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Research and development for the pharmaceutical industry; pharmaceutical research and development; pharmaceutical products development; consultancy relating to pharmaceutical research and development.